ABOUT Prof. dr. Tatjana Milenkovich

specialist in internal medicine, endocrinologist

Prof. dr. Tanja Milenkovich, specialist in internal medicine, endocrinologist. Full professor of internal medicine at the Medical Faculty, Skopje, head of the department for endocrinology, diabetes and metabolic disorders. She has been a consultant in Internal Medicine Center SRCE since 2021..



PhD – 1999, Medical Faculty, Skopje

Master’s degree – 1990, Medical Faculty, Skopje

Medical Doctor – 1984, Medaical faculty, Skopje



Subspecialist in endocrinology – 2004

Subspecialist in internal medicine – 1991



Founder of the department for education of people with diabetes, 1995

Department for endocrinology, diabetes and metabolic disorders, Skopje, since 1985 until present days Consultant in the Internal Medicine Center SRCE, 2021



Teaching since 1986, beginning as junior assistant and progressing to a full professor in 2012


Education programs:

Diabetes center, Ipswich – England 2000

Steno Center Copenhagen, Denmark 1994


Participation in national and international projects:

Programs for Education of People with Diabetes – World Health Organization in Macedonia, 2001 – 2002

Evidence Based Medicine – leader of the endocrinology team, Ministry of Health, 2005 – 2006

Evidence Based Medicine – leader of the endocrinology team, Ministry of Health, 2012 – 2014

Diabetes Prevention Project, HIF – 2013

Leader of the endocrinology team – education of doctors, 2014


Participation in clinical trials, including GCP Training:

Researcher in the following clinical trials:


BLOSSOM (Efficacy of pregabalin and duloxetine in patients with painful diabetic peripheral neuropathy (PDPN), 2019

NN9535-4386 – SUSTAINE 11 (Effect of Semaglutide Once-weekly Versus Insulin Aspart Three Times Daily, Both as Add on to Metformin and Optimised Insulin Glargine (U100) in Subjects With Type 2 Diabetes), 2019

EFC 1475 – SCORED (Sotagliflozin in Patients with Diabetes and and Chronic Kidney Disease), 2019 y.

LPS 15017 Global premix (A multi-center open-label parallel group randomized controlled trial to compare iGlarLixi versus premixed insulin in patients with type 2 diabetes who have failed to achieve glycemic control with basal insulin and oral antidiabetic agents, 2019

NN9535-3625 SUSTAINE 4 (Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects with Type 2 Diabetes), 2015

NN9535-3625 (Efficacy and safety of semaglutide once weekly versus insulin glargine once daily as add-on to metformin with or without sulphonylurea in insulin-naïve subjects with type 2 diabetes), 2014

NN5401-3816 (A trial investigating the efficacy and safety of insulin degludec/insulin aspart once daily plus insulin aspart for the remaining meals versus insulin detemir once or  twice daily plus meal time insulin aspart in children and adolescents with type 1 diabetes mellitus), 2013

NN1250-3561 (A trial investigating the efficacy and safety of insulin degludec in children and adolescents with type 1 diabetes mellitus), 2012

ANA3786 (Efficacy and safety of basal-bolus therapy, comparing stepwise addition of insulin aspart versus complete basal-bolus regimen), 2010

NN1250-3585/3725 (Comparison of NN1250 plus insulin detemir plus insulin aspart in type 1 diabetes)

Biasp), 2010

NN1250-3668 (Comparison of NN1250 with insulin glargine in type 2 diabetes), 2009

NN2211-1797, (Effect of liraglutide or exenatide added to an ongoing treatment on blood glucose control in subjects with type 2 diabetes), 2007

NN1998-1682, (Safety and efficacy of inhaled pre-prandial human insulin in type 2 diabetes), 2006

NN304-1595, (Comparisan of insulin detemir with NPH insulin in type 2 diabetes), 2005

AGEE/DCD/080, NovoNorm IST, 1996


GCP Researcher Course Training, September 2008

GCP Researcher Course Training, April 2000




  • Internal Medicine, together with S. Genadieva and others, 2021
  • Medical Nutrition, together with P. Mishevska and others, 2016
  • Education for Treatment of People with Diabetes by Tatjana Milenkovich, 2005
  • Clinical Trials in Internal Medicine, Internal Propaedeutics, pages: 395-400, 430-434, 2004
  • Practicum in Clinical Endocrinology by Tatjana Milenkovich and Goran Petrovski, 2003
  • Endocrinology Tests, Dimitrovski and associates


More than 100 scientific papers in various national and international magazines.

Invited to lecture and participate in regional congresses, Europe, EASD post-graduate courses, India, and the World IDF Congresses.



Subspecialist certificate – 2004

Specialist certificate – 1991

National Certificate – 1984


Other activities associated with the professional qualifications:

President of the Macedonian Diabetes Association – currently

President of the Macedonian Association of Endocrinologists and Diabetologists since 2014 – present days

President of the 4th Macedonian Congress of Endocrinology, Diabetes and Metabolic Disorders, 2014

President and founder of the First Diabetes Days, 2016

President of the Second Diabetes Days, 2017

President of the 5th Macedonian Congress of Endocrinology and Diabetology and the Third Diabetes Days, 2018

President of the Fourth Diabetes Days, 2019

President of the Fifth Diabetes Days, 2020

EASD, ADA, IDF, DESG  member (executive committee member)

IDF Europe Board member for the biennale 2019/2021

DESG elected president (since 2022 )